Requirement for Specific Proteases in Cancer Cell Intravasation as Revealed by a Novel Semiquantitative PCR-Based Assay

[1]  L. Matrisian,et al.  Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.

[2]  K. Isselbacher,et al.  Early events of metastasis in the microcirculation involve changes in gene expression of cancer cells. Tracking mRNA levels of metastasizing cancer cells in the chick embryo chorioallantoic membrane. , 1997, The American journal of pathology.

[3]  L. Ossowski,et al.  Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy , 1997, The Journal of cell biology.

[4]  L. Zanetta,et al.  Control of type IV collagenase activity by components of the urokinase–plasmin system: a regulatory mechanism with cell‐bound reactants , 1997, The EMBO journal.

[5]  J. Koster,et al.  Coordinated expression of matrilysin during TPA-induced apoptosis of LNCaP cells: two parallel processes affected by TPA. , 1997, Cancer letters.

[6]  R. Muschel,et al.  Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. , 1996, Cancer research.

[7]  R. Khokha,et al.  Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Rees,et al.  Investigation of the effect of BB-94 (batimastat) on the colonization potential of human lymphoma cells in SCID mice. , 1996, Cancer letters.

[9]  S. Eccles,et al.  Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). , 1996, Cancer research.

[10]  E. Lengyel,et al.  Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. , 1995, Cancer research.

[11]  H. Kobayashi,et al.  Inhibition of the Metastasis of Lewis Lung Carcinoma by Antibody Against Urokinase-Type Plasminogen Activator in the Experimental and Spontaneous Metastasis Model , 1994, Thrombosis and Haemostasis.

[12]  D. Defouw,et al.  The microvascular unit of the 6-day chick chorioallantoic membrane: a fluorescent confocal microscopic and ultrastructural morphometric analysis of endothelial permselectivity. , 1993, Microvascular research.

[13]  F. Balkwill,et al.  A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. , 1993, Cancer research.

[14]  L. Ossowski.  Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase. , 1992, Cancer research.

[15]  R. Schultz,et al.  Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. , 1990, Cancer research.

[16]  K. Matsumoto,et al.  A study of an in vitro model for invasion of oral squamous cell carcinoma. , 1989, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[17]  R. Miskin,et al.  Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells , 1989, Molecular and cellular biology.

[18]  L. Ossowski,et al.  In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase , 1988, The Journal of cell biology.

[19]  E. Appella,et al.  Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. , 1988, Cancer research.

[20]  L. Ossowski.  Plasminogen activator dependent pathways inthe dissemination of human tumor cells in the chick embryo , 1988, Cell.

[21]  L. Ossowski,et al.  Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness. , 1987, Cancer research.

[22]  L. Ossowski,et al.  Antibodies to plasminogen activator inhibit human tumor metastasis , 1983, Cell.

[23]  L. Ossowski,et al.  Changes in malignant phenotype of a human carcinoma conditioned by growth environment , 1983, Cell.

[24]  J. Quigley,et al.  Transepithelial invasion and intramesenchymal infiltration of the chick embryo chorioallantois by tumor cell lines. , 1982, Cancer research.

[25]  L. Ossowski,et al.  Experimental model for quantitative study of metastasis. , 1980, Cancer research.

[26]  I. Fidler,et al.  In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. , 1980, Cancer research.

[27]  Y. Endo,et al.  Relationship between expression of plasminogen activator system and metastatic ability in human cancers. , 1996, International journal of oncology.

[28]  D. Rifkin,et al.  Biology and biochemistry of proteinases in tumor invasion. , 1993, Physiological reviews.

[29]  Y. Hayashizaki,et al.  Revision of consensus sequence of human Alu repeats--a review. , 1987, Gene.

[30]  E. Jaffe.  Culture and identification of large vessel endothelial cells , 1984 .

[31]  L. Liotta,et al.  Interactions of tumor cells with whole basement membrane in the presence or absence of endothelium. , 1982, Progress in clinical and biological research.

[32]  T. M. Bell.  THE CHICK EMBRYO , 1965 .